Genesee-Transit Pediatrics Ll Buffalo, NY - 14225

Genesee-Transit Pediatrics Ll is categorized under Pediatricians in Buffalo, NY and active since 2001.

Genesee-Transit Pediatrics Ll was established in 2001, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Pediatricians business, which does work in the B2C market, and is classified as a Pediatricians, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Ferdinand Yeates at the company’s single location by writing to 2865 Genesee St, Buffalo, New York NY 14225 or by phoning (716) 895-2590. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Genesee-Transit Pediatrics Ll
Contact Person: Ferdinand Yeates
Address: 2865 Genesee St, Buffalo, New York 14225
Phone Number: (716) 895-2590
Website Address: gtpediatrics.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2001
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Pediatricians
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Genesee-Transit Pediatrics Ll was started in 2001 to provide professional Pediatricians under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Ferdinand Yeates for inquiries that concern Genesee-Transit Pediatrics Ll by calling the company number (716) 895-2590, as your correspondence is most welcome. Additionally, the physical location of the single location of Genesee-Transit Pediatrics Ll can be found at the coordinates 42.92344,-78.77902 as well as the street address 2865 Genesee St in Buffalo, New York 14225.

For its online presence, you may visit Genesee-Transit Pediatrics Ll’s website at gtpediatrics.com and engage with its social media outlets through on Twitter and on Facebook.